| http://www.w3.org/ns/prov#value | - It has been characterized in more than 500 patients to date and has been reported worldwide in various ethnic groups.ALPS is clinically heterogeneous with the following primary clinical signs: lymphoproliferation, manifesting as lymphadenopathy and hepatosplenomegaly with or without hypersplenism, often improving with age, autoimmune disease, mostly involving blood cells, and an increased risk of
|
